FindTrial
Sign In

Identification of the factors that leads to pulmonary tuberculosis and identification of the factors that affect the treatment outcome.

Assessment of risk factors for pulmonary tuberculosis and factors responsible for treatment outcome.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/04/032908
Enrollment
100
Registered
2021-04-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A150- Tuberculosis of lung

Interventions

Control Intervention1: NIL: NIL

Sponsors

Viramgami karan hiteshkumar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (1)Age more than 18 years. (2)Patients with microbiologically confirmed cases (Sputum positive for AFB smear or CB-NAAT, BAL positive for AFB smear or culture or CB-NAAT) of pulmonary tuberculosis at the time of diagnosis (3)Newly diagnosed patients or already diagnosed and on the anti-tubercular treatment having all previous investigations and treatment records (4)Willing to participate and give consent

Exclusion criteria

Exclusion criteria: (1)Serological evidence of an acute infection with hepatitis B or C. (2) Patient with HIV. (3) Patients with malignancy.

Design outcomes

Primary

MeasureTime frame
Cured from the diseaseTimepoint: End of 6months.—

Secondary

MeasureTime frame
Identification of adverse drug reactions of antitubercular drugs and identification of risk factors for pulmonary tuberculosis.Timepoint: End of 2nd month and 6months.—

Countries

India

Contacts

Public ContactKARAN HITESHKUMAR VIRAMGAMI

GMERS medical collage and hospital Gotri Vadodara

dranandkpatel@gmail.com9879771079

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026